13 August 2021
Gall recently obtained a proprietary injunction in Hong Kong for its clients, Ms Zhao Long and a British Virgin Islands (“BVI”) company Endushantum Investments Co., Ltd. (“Endushantum”) in a complex cross-border dispute involving the shareholdings in Lunan Pharmaceutical Group Corporation (“Lunan”), a significant PRC pharmaceutical company, and other group companies (collectively, the “PRC Shares”).
On 20 July 2021, the BVI Commercial Court handed down a judgment confirming Ms Zhao Long’s ownership of shares in Endushantum (the “BVI Judgment”), which has attracted considerable attention across different jurisdictions.
Before the BVI Judgment was handed down, the PRC Shares held had been transferred to two Hong Kong companies (the “HK Companies”) which were said to be holding the shares as nominees. In order to preserve the PRC Shares in favour of their beneficial owner, Ms Zhao, Gall successfully obtained a proprietary injunction from the Hong Kong Courts earlier this month to prohibit the HK Companies from disposing of or otherwise dealing with the PRC Shares.
